search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
458


Table 1. Blood Culture or Intraluminal Catheter Colonization With and Without Use of Antiseptic Barrier Caps Reference Study Design


13


Quasi-experimental, single-center


Blood culture contamination drawn through peripherally inserted central catheters before use of antiseptic barrier caps


2.5% (10/400) 14


Quasi-experimental, multi-center


Colonization of intraluminal catheter blood before use of antiseptic barrier caps in a hospital system


12.4% (40/323)


Colonization of intraluminal catheter blood before use of antiseptic barrier caps in one hospital


12.5% (15/120) 15


Quasi-experimental, single-center


Blood culture contamination drawn through central venous catheters before use of antiseptic barrier caps in high-risk patients


2.0% (110/9,267)


Blood culture contamination drawn through central venous catheters before use of antiseptic barrier caps in general oncology patients


3.7% (576/15,730)


Leonard A. Mermel


Outcome Measures and Contamination Rates


Blood culture contamination drawn through peripherally inserted central venous catheters after routine use of antiseptic barrier caps


0.5% (1/222)a


Colonization of intraluminal catheter blood with routine use of antiseptic barrier caps in a hospital system


5.5% (28/507)b


Colonization of intraluminal catheter blood with routine use of antiseptic barrier caps in one hospital


6.2% (22/354)


Blood culture contamination drawn through central venous catheters with routine use of antiseptic barrier caps in high-risk patients


0.7% (64/9,415)d


Blood culture contamination drawn through central venous catheters before use of antiseptic barrier caps in general oncology patients


1.7% (113/6,587)þ


Note. RR, risk ratio; CI, confidence interval. aRR, 0.18; 95% CI, 0.02–1.37; P = 0.10. bP < .001. cP = .01 when comparing before barrier cap use and with barrier cap use; P = .003 when comparing with barrier cap use and after discontinued barrier cap use. dP < .001.


significant reductions in these infections when unique antiseptic barrier caps are used.11,12 Thus, one would expect a commensu- rate reduction in blood culture contamination. In the peer- reviewed literature, 3 studies assessed this issue and found a reduction in intraluminal colonization or blood culture contami- nation (Table 1).13–15 In these studies, no data were provided regarding contamination of simultaneously obtained, percutane- ously-drawn, blood cultures. Notably, the use of antiseptic barrier caps is not without complications; pediatric patients have swal- lowed these devices.16 Blood cultures collected through a short-term peripheral intra-


venous catheter during insertion in pediatric17 and adult patients18 have a significantly greater risk of contamination compared to per- cutaneously-drawn cultures. Blood cultures drawn during central venous catheter insertion in an intensive care unit have a signifi- cantly higher risk of contamination compared to percutaneously- drawn cultures; however, contamination of blood cultures drawn during arterial catheter insertion was not significantly different than percutaneously-drawn cultures.19 From this review, it is evident that (1) a multimodal program


can significantly reduce catheter-drawn blood culture contamina- tion; (2) the use of antiseptic barrier caps can reduce the risk of catheter-drawn blood culture contamination; and (3) blood


cultures should not be obtained during insertion of short-term peripheral intravenous catheters or central venous catheters. No published studies have assessed contamination rates when percu- taneously-drawn blood cultures are done with technologies that divert an initial aliquot of blood compared with catheter-drawn cultures when antiseptic barrier caps are used and cultures are obtained from the catheter hub or from a new needleless connector after the old connector is discarded. It is important to remember that catheter colonization is not static


— it is a continuous process.


Catheter lumens can become colonized over time,20 which can lead to a bloodstreaminfection. As such, catheter-drawn blood cultures may reveal such colonization before a true bloodstream infection is evident or may reveal colonization in a patient who had recent or transient bacteremia from the colonized catheter that was cleared and undetected by percutaneously-drawn cultures. In situ diagno- sis of catheter-related bloodstream infection, in contradistinction to the less-specific central-line–associated bloodstream infection, requires catheter-drawn and percutaneously-drawn cultures.1 Basedonthe publishedliterature, bloodcultures shouldbe


obtained percutaneously when possible. Definitive in situ diagnosis of catheter-related bloodstream infection requires catheter-drawn cultures,which should be obtained froma catheter hub after removal of the old needleless connector that was protected with an antiseptic


Colonization of intraluminal catheter blood after discontinued use of antiseptic barrier caps in one hospital


12.6% (33/261)c


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122